What are the Ohio DEA guidelines for nurse practitioners prescribing acute pain medications, including non‑opioid and opioid options, DEA registration, PDMP reporting, dosage limits, and required supervision?

Ohio DEA Guidelines for Nurse Practitioners Prescribing Acute Pain Medications

Nurse practitioners in Ohio must obtain DEA registration to prescribe controlled substances including opioids, comply with PDMP reporting requirements, and follow state-specific supervision requirements that vary based on their practice authority level, while adhering to CDC guidelines that prioritize nonopioid therapies for acute pain management.

DEA Registration Requirements

All NPs who prescribe controlled substances, including opioids, must:

• Obtain their own DEA registration number
• Register separately from any supervising physician
• Renew registration every 3 years
• Maintain registration in good standing to prescribe Schedule II-V medications

Ohio-Specific Prescribing Framework

Supervision Requirements

Ohio operates under a reduced practice authority model for NPs, meaning:

• NPs require a Standard Care Arrangement (SCA) with a collaborating physician 1
• The SCA must outline prescriptive authority scope
• This represents a key barrier compared to full practice authority states 1

PDMP (Prescription Drug Monitoring Program) Requirements

• Mandatory PDMP checks before prescribing opioids 2
• Must verify no concurrent opioid prescriptions that could lead to dangerous cumulative dosages
• Check for concurrent benzodiazepines or other sedating medications 2

Acute Pain Prescribing Guidelines

First-Line Approach: Nonopioid Therapies

Maximize nonopioid options before considering opioids 2:

• Pharmacologic: NSAIDs, acetaminophen (topical or oral)
• Nonpharmacologic: Ice, heat, elevation, rest, immobilization, exercise
• These are at least as effective as opioids for common acute pain conditions including low back pain, neck pain, musculoskeletal injuries, minor surgeries, dental pain, kidney stones, and headaches 2

When Opioids Are Appropriate

Opioids have a role for 2:

• Severe traumatic injuries (crush injuries, burns)
• Invasive surgeries with moderate-to-severe postoperative pain
• Other severe acute pain when NSAIDs are contraindicated or ineffective

Opioid Prescribing Specifics

Dosage and Duration Limits:

• Prescribe immediate-release formulations only 2
• Use the lowest effective dose 2
• Initial supply: ≤5 days for most acute pain 3
• Longer duration only if pain related to trauma/surgery with expected duration >5 days 3
• Ohio's 2017 Opioid Prescribing Guidelines specifically limit narcotic prescriptions for acute pain 4

Prescribing Instructions:

• Write as "as needed" (PRN) rather than scheduled dosing 2
• Example: "Hydrocodone 5mg/acetaminophen 325mg, one tablet not more frequently than every 4 hours as needed for moderate to severe pain" 2
• Avoid scheduled dosing (e.g., "one tablet every 4 hours") 2

If opioids used around-the-clock for >few days:

• Include a taper plan to prevent withdrawal 2

Medications to Avoid

Never prescribe 3:

• Codeine or tramadol for patients <12 years
• Codeine or tramadol for adolescents 12-18 years with obesity, obstructive sleep apnea, or severe lung disease
• Codeine or tramadol for post-tonsillectomy/adenoidectomy pain in patients <18 years
• Codeine or tramadol for breastfeeding patients

Risk Mitigation Requirements

Naloxone Co-Prescribing

• Offer naloxone to patients receiving opioids, particularly if patient or household member has overdose risk factors 2
• Provide education on naloxone use 2

Patient Education (Mandatory Discussion Points)

Before prescribing opioids, discuss 2:

• Short-term use can lead to long-term dependence
• Plan for discontinuation as pain resolves
• Risks: respiratory depression, death, opioid use disorder (risks increase with higher dosages)
• Avoid concurrent use with benzodiazepines, alcohol, other sedatives, or illicit drugs
• Safe storage in locked location
• Safe disposal options for unused medication
• Risks to household members (children, pets) from unintentional ingestion
• Goal is to reduce pain to manageable levels, not eliminate it entirely
• Effects on ability to operate vehicles/machinery
• Avoid taking additional acetaminophen-containing products if combination formulation prescribed

High-Risk Situations Requiring Extra Caution

• Concurrent benzodiazepines or sedating medications 2, 1
• Sleep apnea, pregnancy, renal/hepatic insufficiency 2
• Mental health conditions or substance use disorders 2
• Patients already on long-term opioids for chronic pain 2

Special Considerations for Patients on Chronic Opioids

If treating acute pain in patients already receiving long-term opioids 2:

• Prioritize nonopioid medications when possible
• If additional opioids required for severe acute pain:
  • Continue only for duration of severe pain
  • Return to baseline opioid dosage ASAP
  • Include taper to baseline if additional opioids used around-the-clock for >few days

Documentation and Follow-Up

• Establish communication protocols for patients to report severe/uncontrolled pain 2
• Arrange timely reassessment and management
• Use opioid dose conversion guides when needed 5
• Avoid co-administration of parenteral and oral opioids 5

Common Pitfalls to Avoid

1. Prescribing scheduled dosing instead of PRN - This increases tolerance and withdrawal risk
2. Failing to check PDMP - May miss dangerous drug combinations or "doctor shopping"
3. Not providing naloxone - Missed opportunity for overdose prevention
4. Inadequate patient education - Patients unaware of addiction risks and safe storage
5. Prescribing >5 days initially - Ohio guidelines specifically limit this 4
6. Using opioids as monotherapy - Should always be part of multimodal approach 3

Evidence Quality Note

The CDC 2022 guidelines 2 represent the highest quality federal guidance (Category A and B recommendations), though much is based on expert consensus (evidence type 3-4) rather than randomized trials. Ohio-specific research 4 demonstrates that state guidelines successfully reduced opioid prescribing after total joint arthroplasty, though this led to slightly increased refill requests at follow-up visits. NP prescribing patterns show similar or slightly higher opioid prescribing rates compared to physicians 6, emphasizing the importance of guideline adherence.